PCI Biotech Holding ASA
OSE:PCIB

Watchlist Manager
PCI Biotech Holding ASA Logo
PCI Biotech Holding ASA
OSE:PCIB
Watchlist
Price: 0.252 NOK -1.56% Market Closed
Market Cap: 9.4m NOK

Wall Street
Price Targets

PCIB Price Targets Summary
PCI Biotech Holding ASA

There are no price targets for PCIB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
PCI Biotech Holding ASA Competitors:
Price Targets
QURE
Uniqure NV
138% Upside
LCTX
Lineage Cell Therapeutics Inc
126% Upside
LVTX
LAVA Therapeutics NV
20% Downside
ANAB
AnaptysBio Inc
25% Upside
ARQT
Arcutis Biotherapeutics Inc
15% Upside
INCY
Incyte Corp
6% Downside
ZNTL
Zentalis Pharmaceuticals Inc
287% Upside
FYB
Formycon AG
111% Upside

Revenue
Forecast

Revenue Estimate
PCI Biotech Holding ASA

For the last 13 years the compound annual growth rate for PCI Biotech Holding ASA's revenue is -1%. The projected CAGR for the next 3 years is 9%.

-1%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
PCI Biotech Holding ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
PCI Biotech Holding ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PCIB's stock price target?
Not Available

PCIB doesn't have any price targets made by Wall Street professionals.

What is PCI Biotech Holding ASA's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for PCI Biotech Holding ASA's revenue is -1%. The projected CAGR for the next 3 years is 9%.

Back to Top